Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice

APMIS

Volumn 120, Issue 10, 2012, Pages 786-793

  Schennings, Torgny ^a   Farnebo, Filip ^a   Szekely, Laszlo ^a   Flock, Jan Ingmar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Immunization; Snake venomA; Staphylococcus aureus; Vaccine; Wound infection

Indexed keywords

ABISCO 100; BACTERIAL PROTEIN; CLUMPING FACTOR A; EXTRACELLULAR ADHERENCE PROTEIN; EXTRACELLULAR FIBRINOGEN BINDING PROTEIN; FIBRONECTIN BINDING PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOLOGICAL ADJUVANT; RECOMBINANT PROTEIN; SNAKE VENOM; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPERIMENTAL MODEL; FEMALE; HISTOLOGY; IMMUNIZATION; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STAPHYLOCOCCUS INFECTION; TISSUE NECROSIS; WEIGHT REDUCTION; WOUND HEALING; WOUND INFECTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BOTHROPS; COAGULASE; CROTALID VENOMS; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; NECROSIS; RECOMBINANT PROTEINS; RNA-BINDING PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; WOUND INFECTION;

EID: 84866154771     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02907.x     Document Type: Article

References (34)

1. Al-Obeid S, Haddad Q, Cherkaoui A, Schrenzel J, Francois P. First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia. J Clin Microbiol 2010;48:2199-204.
2. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001;9:486-93.
3. Garcia-Lara J, Foster SJ. Anti-Staphylococcus aureus immunotherapy: current status and prospects. Curr Opin Pharmacol 2009;9:552-7.
4. Thomsen LE, Gottlieb CT, Gottschalk S, Wodskou TT, Kristensen HH, Gram L, et al. The heme sensing response regulator HssR in Staphylococcus aureus but not the homologous RR23 in Listeria monocytogenes modulates susceptibility to the antimicrobial peptide plectasin. BMC Microbiol 2010;10:307.
5. Saravia-Otten P, Gutierrez JM, Arvidson S, Thelestam M, Flock JI. Increased infectivity of Staphylococcus aureus in an experimental model of snake venom-induced tissue damage. J Infect Dis 2007;196:748-54.
6. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994;11:237-48.
7. Signas C, Raucci G, Jonsson K, Lindgren PE, Anantharamaiah GM, Hook M, et al. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Nat Acad Sci USA 1989;86:699-703.
8. Domanski PJ, Patel PR, Bayer AS, Zhang L, Hall AE, Syribeys PJ, et al. Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus. Infect Immun 2005;73:5229-32.
9. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001;184:1572-80.
10. Vernachio J, Bayer AS, Le T, Chai YL, Prater B, Schneider A, et al. Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 2003;47:3400-6.
11. Rennermalm A, Li YH, Bohaufs L, Jarstrand C, Brauner A, Brennan FR, et al. Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine 2001;19:3376-83.
12. Schennings T, Heimdahl A, Coster K, Flock JI. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog 1993;15:227-36.
13. Brennan FR, Jones TD, Longstaff M, Chapman S, Bellaby T, Smith H, et al. Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine 1999;17:1846-57.
14. Arrecubieta C, Matsunaga I, Asai T, Naka Y, Deng MC, Lowy FD. Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice. J Infect Dis 2008;198:571-5.
15. Stranger-Jones YK, Bae T, Schneewind O. Vaccine assembly from surface proteins of Staphylococcus aureus. Proc Nat Acad Sci USA 2006;103:16942-7.
16. Guss B, Flock M, Frykberg L, Waller AS, Robinson C, Smith KC, et al. Getting to grips with strangles: an effective multi-component recombinant vaccine for the protection of horses from Streptococcus equi infection. PLoS Pathog 2009;5:e1000584.
17. Shannon O, Uekotter A, Flock JI. Extracellular fibrinogen binding protein, Efb, from Staphylococcus aureus as an antiplatelet agent in vivo. Thromb Haemost 2005;93:927-31.
18. Zhang X, Liu Y, Gao Y, Dong J, Mu C, Lu Q, et al. Inhibiting platelets aggregation could aggravate the acute infection caused by Staphylococcus aureus. Platelets 2011;22:228-36.
19. Lee LY, Hook M, Haviland D, Wetsel RA, Yonter EO, Syribeys P, et al. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J Infect Dis 2004;190:571-9.
20. Shannon O, Uekotter A, Flock JI. The neutralizing effects of hyperimmune antibodies against extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus. Scand J Immunol 2006;63:184-90.
21. Harraghy N, Hussain M, Haggar A, Chavakis T, Sinha B, Herrmann M, et al. The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology 2003;149:2701-7.
22. Athanasopoulos AN, Economopoulou M, Orlova VV, Sobke A, Schneider D, Weber H, et al. The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 2006;107:2720-7.
23. Chavakis E, Dimmeler S. Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler Thromb Vasc Biol 2002;22:887-93.
24. Xie C, Alcaide P, Geisbrecht BV, Schneider D, Herrmann M, Preissner KT, et al. Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus. J Exp Med 2006;203:985-94.
25. Wang H, von Rohrscheidt J, Roehrbein J, Peters T, Sindrilaru A, Kess D, et al. Extracellular adherence protein of Staphylococcus aureus suppresses disease by inhibiting T-cell recruitment in a mouse model of Psoriasis. J Invest Dermatol 2010;130:743-54.
26. Hussain M, Haggar A, Peters G, Chhatwal GS, Herrmann M, Flock JI, et al. More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. Infect Immun 2008;76:5615-23.
27. Huesca M, Sun Q, Peralta R, Shivji GM, Sauder DN, McGavin MJ. Synthetic peptide immunogens elicit polyclonal and monoclonal antibodies specific for linear epitopes in the D motifs of Staphylococcus aureus fibronectin-binding protein, which are composed of amino acids that are essential for fibronectin binding. Infect Immun 2000;68:1156-63.
28. McGavin MJ, Raucci G, Gurusiddappa S, Hook M. Fibronectin binding determinants of the Staphylococcus aureus fibronectin receptor. J Biol Chem 1991;266:8343-7.
29. Josefsson E, McCrea KW, Ni Eidhin D, O'Connell D, Cox J, Hook M, et al. Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology 1998;144(Pt 12):3387-95.
30. Hienz SA, Schennings T, Heimdahl A, Flock JI. Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis 1996;174:83-8.
31. Patti JM, Bremell T, Krajewska-Pietrasik D, Abdelnour A, Tarkowski A, Ryden C, et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994;62:152-61.
32. Zhou H, Xiong ZY, Li HP, Zheng YL, Jiang YQ. An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model. Vaccine 2006;24:4830-7.
33. Rice K, Huesca M, Vaz D, McGavin MJ. Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus. Infect Immun 2001;69:3791-9.
34. McCarthy AJ, Lindsay JA. Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiol 2010;10:173.